Table 1.
*One ET patient had both CALR and JAK2 V617F mutations; †Negative for JAK2 (V617F and exon 12 mutation), MPL W515, and CALR mutation.
Abbreviations: JAK2, Janus kinase 2; MPL, myeloproliferative leukemia virus oncogene; CALR, calreticulin; PV, polycythemia vera; ET, essential thrombocythemia; PMF, primary myelofibrosis.